India moving from Healthcare Follower to Global Leader in Precision Medicine and Biomanufacturing: MoS (See 'Corp Brief') SECL's Vigilance-led Initiative 'Prayas' Ensures Timely PF & Pension Settlement (See 'Corp Brief') Agrinnovate India presents Rs.3.4 Crore dividend to Chouhan (See 'Corp Brief') 6 Railway Stations in West Bengal redeveloped under Amrit Bharat Station Scheme (See 'Corp Brief') NHAI receives warm response from Bidders for Construction of Kaliabor to Numaligarh Section of NH (See 'Corp Brief') MSDE signs MoU with GATI Foundation to Strengthen Global Skill Mobility (See 'Corp Brief') DFS Secy meets NBFCs to discuss targeted points pertaining to the sector (See 'Corp Brief') 41% of India's Scientists are Women: Chouhan Highlights women Agri-Power (See 'Corp Brief') Companies Act - Technical provisions of Companies Act cannot be relied on to evade compliance with a Court decree prohibiting the judgment debtor from transferring the shares to any third party: HC (See 'Legal Desk') IBA hosts RRB Conclave 2026 on 'Next-Gen Reforms for RRBs' (See 'Corp Brief') MoEFCC organizes Workshop to address Challenge of Elephant-train Collisions (See 'Corp Brief') Govt, Civil Society & Tech leaders unite to build Model for Persons with Hearing Impairment (See 'Corp Brief') PMLA - Appearance of Appellant, ordinarily operating in Mumbai, before SAFEMA Appellate Tribunal at Delhi, does not confer territorial jurisdiction to the Delhi High Court over Appellant: HC (See 'Legal Desk') NHAI gets warm response from Bidders for Four-Laning of Dhamasiya-Bitada in Gujarat (See 'Corp Brief') Metro in India a 'Silent Revolution' transforming Urban Mobility and Society (See 'Corp Brief') CCI approves acquisition by Cube V of road asset business of DYIPL, DVIPL, DGIPL and DTEHPL (See 'Corp Brief') CCI approves acquisition of stake in Curefit Healthcare by MacRitchie Investments (See 'Corp Brief') IBC - Once Resolution Plan is approved by NCLT u/s 31 of IBC, it becomes binding on all stakeholders, and all claims not provided for in plan stand extinguished: HC (See 'Legal Desk') Country ready for any Unprecedented Demand for Coal: Govt (See 'Corp Brief') DPIIT signs MoU with Voltas Limited to support Industry-Start-up Collaboration for Smart Appliance Technologies (See 'Corp Brief') New Delhi Frontier AI Impact Commitments were Signed by 13 Leading Model Providers (See 'Corp Brief') APEDA showcases Agri and Processed Food Export Strength at AAHAR 2026 (See 'Corp Brief') IPR - Party seeking cancellation of registered trademark on grounds of similarity and prior rights must first establish its own prior and continuous use of its mark as trademark: HC (See 'Legal Desk') Capacity Building Commission hosts workshop on sustainable financing & resource mobilisation (See 'Corp Brief') Govt boosts Credit Flow to Agriculture Sector through targeted Policy Measures (See 'Corp Brief') IBC - Application of Discount for Lack of Marketability is permissible valuation methodology under Indian Accounting Standards for determining fair value of unlisted, illiquid shares in context of capital reduction: SC (See 'Legal Desk') IICA holds 4th Batch of Directors' Certification for Defence Officers (See 'Corp Brief') Financial inclusion campaign was held in 2.7 lakh Gram Panchayats and ULBs (See 'Corp Brief') A&C - Award can be set aside only on specific grounds such as being contrary to fundamental policy of Indian law, violating basic notions of morality or justice, or suffering from patent illegality that goes to root of matter: HC (See 'Legal Desk') ICANN85 in Mumbai highlights Collaboration for resilient Internet (See 'Corp Brief') Minister chairs 35th Meeting of Standing Committee of Voluntary Agencies (See 'Corp Brief') A&C - amendment to petition filed u/s 34 of Arbitration Act, cannot be permitted under Order VI Rule 17 of CPC if its effect is to introduce challenge to distinct part of arbitral award: HC (See 'Legal Desk') NITI Aayog convenes Regional Best Practices Seminar (See 'Corp Brief') FTAs opening New Opportunities for Pharma, Healthcare and MedTech Sectors: Goyal (See 'Corp Brief') MSME Ministry promotes Energy Efficiency and Green Practices in MSME Sector (See 'Corp Brief') Transforming Mined Landscapes: NLC India's Journey in Sustainable Mine Restoration (See 'Corp Brief') IEPFA-NCAER jointly organise Investor Education and Protection Workshop (See 'Corp Brief') IPR - Proprietorship of trademark, as general rule, vests in manufacturer who affixes mark on product, not in importer or distributor of those goods: HC (See 'Legal Desk') Chouhan holds post-Budget discussion with coconut farmers in Chennai (See 'Corp Brief') IBC - Creditor cannot be forced to elect its remedy or apportion its claim between principal debtor and guarantor: SC (See 'Legal Desk') IBC - Judicial review by NCLT & NCLAT does not extend commercial wisdom of Committee of Creditors in evaluating and approving resolution plan: SC (See 'Legal Desk') A&C - Pre-award and post-award interest operate in distinct fields and contractual bar applicable to former cannot, by implication, be extended to latter: SC (See 'Legal Desk') MoS interacts with beneficiaries of desalination plant in Kavaratti (See 'Corp Brief') A&C - Court will not grant specific performance of contractual obligation that is contingent upon discretionary approval of third-party government authority: HC (See 'Legal Desk') A&C - Contractual clause that expressly and widely bars payment of interest on ‘any moneys due to contractor' prohibits arbitral tribunal from awarding pre-reference and pendente lite interest on all claims: HC (See 'Legal Desk') Supreme Court Clears Path For Single Insolvency Proceedings Against Linked Group Companies (See CORP EINSICHT)

Print

India moving from Healthcare Follower to Global Leader in Precision Medicine and Biomanufacturing: MoS

Published: Mar 14, 2026

By TIOLCorplaws News Service

NEW DELHI, MAR 14, 2026: INDIA is entering a transformative phase where cutting-edge biotechnology, genomics and multi-omics research are reshaping the future of healthcare, positioning the country as a global hub for precision medicine, biomanufacturing and medical innovation, said Union Minister of State (Independent Charge) for Science & Technology, Earth Sciences and MoS PMO, Personnel, Public Grievances, Pensions, Atomic Energy and Space Dr. Jitendra Singh.

Delivering the inaugural address at the Multi-Omics Summit 2026, organised by the Proteomics Society, India (PSI) with advocacy partnership of the IHW Council, Dr. Jitendra Singh said India has moved from an era where advanced treatment required travelling abroad to a stage where the country is emerging as a global healthcare destination attracting medical tourism through quality and cost-effective care.

He said India's healthcare ecosystem today integrates modern biotechnology, genomics, and AI-driven research with traditional knowledge systems such as Ayurveda, creating a unique model of integrated medicine. The creation of a dedicated Ministry of AYUSH and the expansion of biotechnology research platforms have enabled India to develop innovative healthcare solutions that combine tradition with advanced science.

Highlighting the growing importance of biotechnology in national development, Dr. Jitendra Singh said India is among the first countries to launch a comprehensive BioE3 policy, biotechnology for economy, environment and employment. The policy is designed to accelerate innovation, expand biomanufacturing capacity and generate new opportunities in the bio-economy.

The Minister said India's biotechnology ecosystem has expanded dramatically in the last decade, with more than 11,000 biotech startups today compared to only a few dozen earlier. Government initiatives are strengthening biomanufacturing through dedicated funding, including the Biopharma Shakti scheme with an allocation of Rs.10,000 crore, which will support biomanufacturing hubs, biofoundries and advanced research infrastructure.

Referring to India's large and genetically diverse population, Dr. Jitendra Singh said the country has a unique advantage in genomic research. Through flagship initiatives such as the Genome India Project and the upcoming Phenome India initiative, India has already completed sequencing of around 10,000 genomes and aims to scale this effort significantly. Such large-scale genomic data will help researchers identify disease patterns, develop targeted therapies, and design early interventions even before clinical symptoms appear.

He said integrating genomics, transcriptomics, and proteomics through multi-omics platforms, supported by Artificial Intelligence and Machine Learning, will enable scientists to understand complex disease mechanisms and develop personalised treatments suited to diverse populations.

Dr. Jitendra Singh also highlighted several emerging breakthroughs in biomedical research, including advances in gene-based therapies and nuclear medicine. He cited recent progress in the treatment of diseases such as sickle cell disorder and hemophilia, as well as new therapeutic developments in nuclear medicine for acute lymphoblastic leukemia in children at the Tata Memorial Centre.

The Minister said India is increasingly becoming a hub for collaborative global research, particularly in areas such as multi-omics that require interdisciplinary partnerships across institutions, sectors, and countries. The government is encouraging such collaboration through policy reforms and expanded participation from academia, industry, and startups.

He said recent reforms have also opened the nuclear sector to private participation, enabling greater innovation in nuclear medicine research, which will play an important role in future healthcare technologies when integrated with genomics and precision medicine.

Dr. Jitendra Singh said India has also demonstrated global leadership in preventive healthcare through the development of the world's first DNA-based vaccine, reflecting the country's growing scientific capabilities and its commitment to affordable healthcare solutions.

Calling the present period one of the most exciting phases in the evolution of modern medicine, Dr. Jitendra Singh said the convergence of biotechnology, artificial intelligence, genomics, and digital platforms is creating unprecedented opportunities for healthcare innovation.

He expressed confidence that India's scientific talent, research ecosystem and forward-looking policies will enable the country to not only collaborate globally but also lead future advances in biotechnology and precision medicine.

The summit brought together leading scientists, researchers, clinicians, biotechnology innovators, and industry experts to discuss the latest developments in multi-omics research and its potential to transform healthcare, diagnostics, and drug discovery.

TIOL CORP SEARCH

TIOL GROUP WEBSITES

taxindiaonline
taxindiainternational
tioltube
TKF
TIOLawards
A TIOL Website. Copyright © 2025 TIOLcorplaws.com All rights reserved.